Showcase Your Work

This informal session gives you dedicated time to connect with the cell therapy process development community in a relaxed setting. Some of the best conversations happen away from the main stage. With a room full of PD, QC, MSAT, and Analytical Development experts actively looking to share and learn, it's your chance to present your own work and get direct feedback from the people who matter most.

  • Demonstrate your thought leadership in cell therapy process development and automation.
  • Gain visibility by showcasing your process innovations to a highly targeted PD audience.
  • Receive direct feedback from peers navigating the same scale-up and manufacturing challenges you are.
  • Attract collaborators and partners who are actively looking for solutions to move their programs forward.
Viewing poster
poster session socialising
Explaining poster

How to Submit Your Poster

Register your place to attend the 5th Process Development & Automation for Cell Therapies Summit

  • Submit an abstract for review to showcase your poster during the Poster Session
  • You will be notified once your abstract has been accepted, along with printing and size requirements. We request an online PDF of your poster 2 weeks before the summit
  • Poster Session Date: July 15th, 2026
  • Abstract Submission Deadline: July 1st, 2026

 

T&Cs

  • Posters should not be used for sales and marketing purposes
  • If your company offers pay-for services, you will need to submit your poster request to our partnerships team - sponsor@hansonwade.com
  • All abstracts are subject to approval by the conference organizers, who reserve the right to reject submissions

Explore the Full Event Guide

  • Hear from 18+ expert speakers covering the full cell therapy development pipeline from early clinical to commercial.
  • Gain 6+ hours of late and commercial stage presentations and panel discussions you can apply immediately.
  • Connect and Network with 30% of speakers from Top 20 global biopharma companies.
  • 65:35 autologous to allogeneic content split across two days.
  • Gain the opportunity to Join exclusive roundtables on in vivo cell therapy process development to showcase how the process will adapt to future advances.
71163